Flagellate purpura associated with COVID-19 vaccination.
E Heck, B D Rankin, M Schneider, V H Prajapati
Author Information
- E Heck: Division of Dermatology, Department of Medicine, University of Calgary, Calgary, Alberta, Canada. ORCID
- B D Rankin: Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada. ORCID
- M Schneider: Department of Pathology and Laboratory Medicine, University of Calgary, Calgary, Alberta, Canada.
- V H Prajapati: Division of Dermatology, Department of Medicine, University of Calgary, Calgary, Alberta, Canada. ORCID
No abstract text available.
- J Eur Acad Dermatol Venereol. 2021 Nov;35(11):e711-e714
[PMID: 34166540]
- J Eur Acad Dermatol Venereol. 2021 Sep;35(9):e548-e551
[PMID: 34021625]
- Int J Dermatol. 2017 Apr;56(4):461-463
[PMID: 28102584]
- Lancet. 2021 Jan 9;397(10269):99-111
[PMID: 33306989]
- J Am Acad Dermatol. 2021 Jul;85(1):46-55
[PMID: 33838206]
- Int J Dermatol. 2006 May;45(5):627-31
[PMID: 16700810]
- Clin Dermatol. 2021 May-Jun;39(3):523-531
[PMID: 34518015]
- Contact Dermatitis. 1992 Aug;27(2):65-70
[PMID: 1395630]
COVID-19
COVID-19 Vaccines
Humans
Purpura
SARS-CoV-2
Vaccination
